Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3176 |
|
Actual shortage: | 259 (8%) | |
Anticipated shortage: | 5 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2903 (91%) | |
Discontinuation Reports |
355 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 333 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
33 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Actual shortage | 2024-09-20 | 2024-09-20 | 238245 |
APO-CLONAZEPAM | 0.5MG | TABLET | Actual shortage | 2024-09-20 | 2024-09-20 | 238242 |
APO-RIVASTIGMINE | 6MG | CAPSULE | Actual shortage | 2024-09-20 | 2024-09-20 | 238239 |
APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-09-20 | 2024-09-20 | 238236 |
APO-CANDESARTAN TABLETS | 16MG | TABLET | Actual shortage | 2024-09-20 | 2024-09-20 | 238233 |
APO-DESMOPRESSIN | 0.2MG | TABLET | Actual shortage | 2024-09-20 | 2024-09-20 | 238230 |
APO-FELODIPINE | 10MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-09-12 | 2024-09-12 | 237378 |
APO-NAPROXEN | 500MG | TABLET | Actual shortage | 2024-09-12 | 2024-09-12 | 237375 |
APO-CEFADROXIL | 500MG | CAPSULE | Actual shortage | 2024-09-12 | 2024-09-12 | 237372 |
APO-MIRTAZAPINE | 45MG | TABLET | Resolved | 2024-09-12 | 2024-09-20 | 237369 |
APO-MONTELUKAST | 10MG | TABLET | Actual shortage | 2024-09-12 | 2024-09-12 | 237363 |
APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Actual shortage | 2024-09-12 | 2024-09-20 | 237360 |
APO-MELOXICAM | 7.5MG | TABLET | Actual shortage | 2024-09-12 | 2024-09-12 | 237357 |
APO-DASATINIB | 100MG | TABLET | Resolved | 2024-09-12 | 2024-09-20 | 237354 |
ALYSENA 21 | 20MCG 100MCG | TABLET | Resolved | 2024-09-12 | 2024-09-20 | 237351 |
APO-VARENICLINE | 1MG | TABLET | Actual shortage | 2024-09-12 | 2024-09-12 | 237348 |
APO-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2024-09-05 | 2024-09-05 | 236875 |
APO-ATOMOXETINE | 25MG | CAPSULE | Actual shortage | 2024-09-05 | 2024-09-05 | 236872 |
APO-AZITHROMYCIN Z | 250MG | TABLET | Actual shortage | 2024-09-05 | 2024-09-05 | 236867 |
APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2024-09-05 | 2024-09-20 | 236864 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2019-02-01 | 2019-02-02 | 74366 |
IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-01-07 | 71436 |
APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |